PerkinElmer, Inc., has announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec).

PerkinElmer, Inc. has announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit.

Company expands SARS-CoV-2 assay portfolio with RT-PCR and next generation sequencing solutions to identify mutations associated with SARS-CoV-2 variants.

La Jolla Institute for Immunology (LJI) has announced that it has signed a licensing agreement with Leinco Technologies, Inc. Leinco also provides custom manufacturing services to the diagnostic and biopharmaceutical industries to leverage proprietary COVID-19 antibodies developed at LJI.

At the virtual 17th US HUPO Conference, Bruker Corporation announced progress with several collaborations in deep, unbiased plasma proteomics, leveraging the speed, sensitivity and dynamic range of 4D proteomics on timsTOF Pro systems.

IL-6 assay aids in care management by determining patients at risk for intubation with mechanical ventilation.

Eppendorf has developed the brand new VisioNize® pipette manager and is on its way towards digitalization in manual pipetting.

108Labs has announced the discovery of novel secretory antibody biosynthesis in the development of Colostrupedics™ whole-human infant formula.

Cytel Inc. has launched East Bayes®, an enhanced web-based extension of the East® platform that enables adoption of the most computationally intensive Bayesian clinical trial designs – without the need for powerful on-site computers.

First and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19.